Laxxon Medical Granted U.S. Patent for the Sequential Release of Multiple Drugs Within Pharmaceutical Dosage Forms

September 22, 2022

Evonik Industries and Laxxon Medical see a future in 3D screen-printed pharmaceuticals

March 8, 2022

3D Screen Printing Enables Application of Integrated QR codes on Pharmaceutical Dosage Forms in Mass Production – A Game Changer

February 3, 2022

Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference

January 7, 2022

Third Quarter Management Report

November 15, 2021

Scalable 3D Screen Printing Technology in Pharmaceutical Manufacturing – High Degree of Freedom in Terms of Drug Choice

April 21, 2021

3D Screen Printing – An Innovative Technology for Large-scale Manufacturing of Pharmaceutical Dosage Forms

November 12, 2020

Laxxon Optimizes the Release of Active Substances Thanks to a Patented, Innovative 3D Screen Printing Process

October 21, 2019

"Nucleus Jena" Project: First Successes Can Be Demonstrated

July 6, 2018

Newsroom Background_edited.jpg

Publications & Press Releases

Laxxon Medical is disrupting the current pharmaceutical drug delivery and manufacturing landscape through our innovative, patented SPID®-Technology (Screen Printing Innovational Drug Technology).

Stay
Informed

Subscribe for updates on our latest developments.

Thanks for submitting!

Contact Us

We're always eager to chat with potential investors and industry partners. Contact us for any additional information you need.

Thanks for submitting!

  • Twitter
  • LinkedIn

135 E 57th Street,

New York, New York 10022

Contact Us

We're always eager to chat with potential investors and industry partners. Contact us for any additional information you need.

All Rights Reserved © 2022 by Laxxon Medical